The Clorox Company (NYSE:CLX) Receives $125.69 Average Price Target from Brokerages

The Clorox Company (NYSE:CLX) has been assigned a consensus recommendation of “Reduce” from the eighteen ratings firms that are currently covering the company, MarketBeat reports. Five equities research analysts have rated the stock with a sell recommendation, twelve have given a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price target among analysts that have covered the stock in the last year is $125.6875.

CLX has been the topic of several research reports. TD Cowen lowered their price objective on shares of Clorox from $120.00 to $117.00 and set a “hold” rating on the stock in a research report on Wednesday, October 1st. Wells Fargo & Company reduced their target price on Clorox from $125.00 to $117.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 4th. Jefferies Financial Group restated a “buy” rating and set a $152.00 price target on shares of Clorox in a research report on Tuesday, November 4th. Deutsche Bank Aktiengesellschaft dropped their price target on Clorox from $128.00 to $121.00 and set a “hold” rating for the company in a research note on Tuesday, November 4th. Finally, The Goldman Sachs Group reduced their price objective on Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a research report on Wednesday, October 1st.

Insider Activity at Clorox

In other Clorox news, Director Pierre R. Breber bought 4,000 shares of Clorox stock in a transaction that occurred on Friday, November 21st. The shares were bought at an average price of $104.13 per share, with a total value of $416,520.00. Following the acquisition, the director owned 13,000 shares in the company, valued at approximately $1,353,690. This trade represents a 44.44% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 0.63% of the company’s stock.

Institutional Trading of Clorox

Several institutional investors have recently added to or reduced their stakes in CLX. CIBC Private Wealth Group LLC increased its holdings in shares of Clorox by 3.7% in the third quarter. CIBC Private Wealth Group LLC now owns 8,969 shares of the company’s stock worth $1,106,000 after buying an additional 318 shares during the period. CIBC Bancorp USA Inc. bought a new position in Clorox during the 3rd quarter valued at approximately $5,576,000. Achmea Investment Management B.V. lifted its holdings in Clorox by 3.1% in the 3rd quarter. Achmea Investment Management B.V. now owns 33,528 shares of the company’s stock worth $4,134,000 after buying an additional 995 shares during the period. WBI Investments LLC bought a new stake in shares of Clorox in the 3rd quarter worth approximately $541,000. Finally, Centaurus Financial Inc. grew its position in shares of Clorox by 8.5% in the 3rd quarter. Centaurus Financial Inc. now owns 1,906 shares of the company’s stock worth $235,000 after buying an additional 150 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Performance

Shares of CLX opened at $106.81 on Friday. Clorox has a 12-month low of $98.20 and a 12-month high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The company has a market cap of $13.03 billion, a PE ratio of 16.38, a price-to-earnings-growth ratio of 0.92 and a beta of 0.52. The stock has a 50-day moving average price of $114.58 and a 200-day moving average price of $121.77.

Clorox (NYSE:CLX) last announced its earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same period last year, the firm posted $1.86 earnings per share. Clorox’s quarterly revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, equities analysts forecast that Clorox will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be given a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date is Wednesday, January 28th. Clorox’s dividend payout ratio (DPR) is presently 77.86%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.